Aniruddh Pradip Patel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atherosclerosis | 6 | 2024 | 3401 | 1.000 |
Why?
|
Lipoprotein(a) | 5 | 2023 | 479 | 0.980 |
Why?
|
Coronary Artery Disease | 10 | 2024 | 6363 | 0.880 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2022 | 393 | 0.630 |
Why?
|
Genome-Wide Association Study | 7 | 2023 | 12604 | 0.580 |
Why?
|
Biological Specimen Banks | 6 | 2022 | 782 | 0.560 |
Why?
|
Genetic Predisposition to Disease | 8 | 2023 | 17768 | 0.530 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15396 | 0.520 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 380 | 0.520 |
Why?
|
Multifactorial Inheritance | 5 | 2023 | 1365 | 0.460 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1309 | 0.430 |
Why?
|
Lipoproteins, LDL | 1 | 2016 | 640 | 0.420 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 664 | 0.380 |
Why?
|
Triglycerides | 2 | 2016 | 2450 | 0.370 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1840 | 0.360 |
Why?
|
Hematopoiesis | 1 | 2019 | 2047 | 0.340 |
Why?
|
DNA Damage | 1 | 2019 | 2439 | 0.320 |
Why?
|
Health Status Disparities | 1 | 2020 | 1832 | 0.310 |
Why?
|
Atrial Fibrillation | 2 | 2022 | 5105 | 0.280 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3384 | 0.270 |
Why?
|
Risk Factors | 16 | 2024 | 73806 | 0.260 |
Why?
|
Genetic Variation | 5 | 2017 | 6548 | 0.230 |
Why?
|
Primary Prevention | 2 | 2021 | 1185 | 0.210 |
Why?
|
Eclampsia | 1 | 2023 | 56 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
Cholesterol, HDL | 3 | 2023 | 1808 | 0.190 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2374 | 0.180 |
Why?
|
Gene Frequency | 3 | 2017 | 3612 | 0.180 |
Why?
|
Hospitalization | 1 | 2020 | 10653 | 0.180 |
Why?
|
Phenotype | 6 | 2023 | 16534 | 0.180 |
Why?
|
Menopause, Premature | 1 | 2021 | 124 | 0.170 |
Why?
|
Penetrance | 1 | 2020 | 388 | 0.160 |
Why?
|
Middle Aged | 18 | 2024 | 219560 | 0.150 |
Why?
|
Heart Failure | 1 | 2022 | 11594 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 517 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 701 | 0.140 |
Why?
|
Humans | 29 | 2024 | 758381 | 0.140 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12440 | 0.130 |
Why?
|
Risk Assessment | 4 | 2022 | 23883 | 0.130 |
Why?
|
Clone Cells | 1 | 2019 | 1660 | 0.130 |
Why?
|
Coronary Disease | 2 | 2023 | 5917 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1788 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2020 | 1475 | 0.120 |
Why?
|
Aged | 11 | 2023 | 168217 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1227 | 0.110 |
Why?
|
Female | 19 | 2024 | 390316 | 0.110 |
Why?
|
Mendelian Randomization Analysis | 1 | 2019 | 993 | 0.110 |
Why?
|
Quality Control | 1 | 2016 | 825 | 0.110 |
Why?
|
Heterozygote | 1 | 2020 | 2797 | 0.110 |
Why?
|
Plaque, Atherosclerotic | 1 | 2024 | 1505 | 0.100 |
Why?
|
Pedigree | 1 | 2020 | 4578 | 0.100 |
Why?
|
Male | 17 | 2024 | 358742 | 0.100 |
Why?
|
Cohort Studies | 6 | 2023 | 41252 | 0.100 |
Why?
|
DNA | 2 | 2023 | 7199 | 0.100 |
Why?
|
Stem Cells | 1 | 2024 | 3521 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2606 | 0.090 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2717 | 0.090 |
Why?
|
Body Height | 1 | 2017 | 1567 | 0.090 |
Why?
|
Adult | 11 | 2023 | 219916 | 0.090 |
Why?
|
Prospective Studies | 4 | 2023 | 54136 | 0.090 |
Why?
|
Exons | 1 | 2016 | 2387 | 0.090 |
Why?
|
Hypertension, Pulmonary | 1 | 2021 | 1565 | 0.090 |
Why?
|
Energy Intake | 1 | 2017 | 2127 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2016 | 4711 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4624 | 0.070 |
Why?
|
HIV Infections | 2 | 2024 | 17275 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2868 | 0.070 |
Why?
|
Lipids | 1 | 2017 | 3326 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7817 | 0.070 |
Why?
|
Incidence | 2 | 2021 | 21273 | 0.060 |
Why?
|
Hypertension | 1 | 2023 | 8503 | 0.050 |
Why?
|
Apolipoproteins B | 1 | 2023 | 385 | 0.050 |
Why?
|
North America | 1 | 2024 | 1276 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 12876 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29558 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39060 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2022 | 22031 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39873 | 0.040 |
Why?
|
Bangladesh | 1 | 2020 | 728 | 0.040 |
Why?
|
Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
Medical History Taking | 1 | 2021 | 772 | 0.040 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
Somatomedins | 1 | 2017 | 178 | 0.030 |
Why?
|
Incidental Findings | 1 | 2021 | 694 | 0.030 |
Why?
|
Genome, Human | 2 | 2020 | 4415 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2017 | 260 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 12870 | 0.030 |
Why?
|
Genotype | 2 | 2021 | 12945 | 0.030 |
Why?
|
Alleles | 2 | 2017 | 6895 | 0.030 |
Why?
|
United States | 1 | 2022 | 72140 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2017 | 605 | 0.030 |
Why?
|
Subtilisins | 1 | 2014 | 81 | 0.030 |
Why?
|
Genetic Code | 1 | 2014 | 138 | 0.030 |
Why?
|
India | 1 | 2020 | 2329 | 0.030 |
Why?
|
Proteoglycans | 1 | 2017 | 801 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 127 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2024 | 4451 | 0.030 |
Why?
|
Hedgehog Proteins | 1 | 2017 | 769 | 0.030 |
Why?
|
Animals | 3 | 2019 | 167777 | 0.020 |
Why?
|
Life Style | 1 | 2023 | 3886 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3812 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25953 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3132 | 0.020 |
Why?
|
Syndrome | 1 | 2017 | 3262 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2017 | 1600 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2017 | 1078 | 0.020 |
Why?
|
Drosophila | 1 | 2017 | 1491 | 0.020 |
Why?
|
Macular Degeneration | 1 | 2017 | 1001 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1651 | 0.020 |
Why?
|
Glycoproteins | 1 | 2017 | 2205 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1074 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9650 | 0.020 |
Why?
|
Heart Diseases | 1 | 2021 | 2782 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12721 | 0.020 |
Why?
|
Linear Models | 1 | 2014 | 5861 | 0.010 |
Why?
|
Proteins | 1 | 2017 | 6026 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29742 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6852 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22006 | 0.010 |
Why?
|
Child | 1 | 2023 | 79813 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12076 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21017 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81107 | 0.000 |
Why?
|